Highlights
Dupixent® PBS listed for severe uncontrolled asthma
New treatment option for patients with severe uncontrolled asthma
Dupixent® PBS listed for severe atopic dermatitis
New treatment option for severe atopic dermatitis.
One team working for patients
Among those with severe disease, many wait for relief from their condition all their lives.
Accessibility Inclusion Plan
We’re proud to continue our efforts in making Sanofi an even more diverse and inclusive working environment, allowing every voice to be heard.
Learn more in our media release.
Learn more in our media release.
The Burden of Non -Melanoma Skin Cancer in Australia
Read the new report that reveals the unseen burden of this deadly disease.
WE ARE SANOFI
Sanofi is driven by science and the patients whose health and well being depend on us.
Our purpose is to bring hope, relief and cures to patients around the world by researching, developing and manufacturing medicines and vaccines, and by accelerating access to scientific innovation.
QUICK LINKS
Careers at Sanofi
Our Products
Our commitment to Transparency
Atopic Dermatitis revealed
Valproate use and pregnancy
Vaccinehub
Sanofi acknowledges the Aboriginal and Torres Strait Islander peoples as the traditional custodians of Australia. We acknowledge and pay our respects to elders past present and future of all the land on which we work and live, and recognise their ongoing connection to land, water and community.